idw – Informationsdienst Wissenschaft

Nachrichten, Termine, Experten

Grafik: idw-Logo
Grafik: idw-Logo

idw - Informationsdienst
Wissenschaft

Science Video Project
idw-Abo

idw-News App:

AppStore

Google Play Store



Instance:
Share on: 
11/23/2021 10:55

Targeting gene expression in mitochondria

Stefan Weller Stabsstelle Unternehmenskommunikation, Presse- und Öffentlichkeitsarbeit
Universitätsmedizin Göttingen - Georg-August-Universität

    Göttingen Scientists of the Cluster of Excellence Multiscale Bioimaging (MBExC) and the Collaborative Research Center 1190 develop novel strategy to investigate gene expression in mitochondria. Published in “Cell”.

    (mbexc/umg) Mitochondria are considered the power plants of cells because they generate energy from our food with the help of oxygen. The machinery required for this is called the respiratory chain. Its central building blocks are formed by mitochondria themselves through the expression of genes of their own genetic material. Malfunctions in gene expression can cause an imbalance of energy production thus leading to severe and often fatal diseases of the nervous and cardiac system. Mechanisms of gene expression in mitochondria are still poorly understood.

    A team of scientists led by Prof. Dr. Peter Rehling, Director of the Institute of Cellular Biochemistry at the University Medical Center Göttingen (UMG), speaker of the Collaborative Research Center SFB1190, and member of the Göttingen Cluster of Excellence "Multiscale Bioimaging: From Molecular Machines to Networks of Excitable Cells" (MBExC) are now one step further. They have developed a completely new strategy that, for the first time, enables to experimentally alter protein formation in mitochondria. The knowledge thus gained also allows conclusions to be drawn about the development of "mitochondrial diseases". The technique was recently published in the renowned journal "Cell".

    Original publication: An in vitro system to silence mitochondrial gene expression. Cruz-Zaragoza LD, Dennerlein S, Linden A,Yousefi R, Lavdovskaia E, Aich A Falk RR, Gomkale R, Schöndorf T, Bohnsack MT, Richter-Dennerlein R, Urlaub H, Rehling P (2021) Cell, 184, 1-14. doi: 10.16/j.cell.2021.09.033.

    Research results in detail
    In the process of mitochondrial gene expression, multiple factors regulate the formation of proteins (translation) for the respiratory chain. Disturbances in this process are associated with a variety of diseases, including cardiovascular disease and nervous system disorders. "In order to develop approaches to prevent disease-relevant disorders, we must first understand the molecular mechanisms of gene expression in mitochondria. Therefore, reductionist approaches are indispensable tools", says Prof. Rehling, senior author of the study. "They allow us to dissect biological processes at different levels and in this way study the function of individual components involved." Such experimental strategies have been lacking until now. A major obstacle to their development lies in the fact that mitochondria are not readily genetically accessible. To solve this problem, the scientists have developed a completely new strategy that enables them to specifically modify translation in purified mitochondria. By using minute amounts of a modified mitochondrial precursor protein, which they efficiently introduce into purified human mitochondria, they are now able to prevent the formation of individual proteins in the mitochondria. "This in vitro system now allows us to study how the loss of expression of a single mRNA affects the physiology and organization of mitochondria, with minimal indirect impact on other processes," says Dr. Luis Daniel Cruz-Zaragoza, scientist at the Department of Cellular Biochemistry, UMG, and first author of the study. Moreover, the scientists were able to easily transfer the technique to purified mitochondria from mice, indicating that it is also applicable in the context of studying disease models. This new experimental strategy is thus also relevant for clinical research, since disorders in mitochondrial gene expression can result in severe diseases of the nervous system and heart, which are often fatal.

    The Göttingen Cluster of Excellence Multiscale Bioimaging: From Molecular Machines to Networks of Excitable Cells (MBExC) is funded since January 2019 in the framework of the Excellence Strategy of the German Federal and State Gov-ernments. Applying a unique and multiscale approach, MBExC investigates the disease-relevant functional units of electrically active cells of heart and brain, from the molecular to the organ level. The MBExC unites numerous partners from the university and extra-university institutions in Göttingen. The overall goal: to under-stand the relationship between heart and brain diseases, to link basic and clinical research, and thus to develop new therapeutic and diagnostic approaches with social implications.

    Further Information
    about Rehling Lab: https://biochemie.uni-goettingen.de
    about MBExC: https://mbexc.de/

    Contact
    University Medical Center Göttingen, Georg-August-University
    Department of Cellular Biochemistry
    Prof. Dr. Peter Rehling
    Humboldtallee 23, D-37073 Göttingen
    Phone +49 (0) 551 / 39-5947
    E-Mail: peter.rehling@medizin.uni-goettingen.de

    Cluster of Excellence Multiscale Bioimaging (MBExC)
    Dr. Heike Conrad (Contact – Press Release)
    Phone 0551 39-61305
    E-Mail: heike.conrad@med.uni-goettingen.de


    Contact for scientific information:

    University Medical Center Göttingen, Georg-August-University
    Department of Cellular Biochemistry
    Prof. Dr. Peter Rehling
    Humboldtallee 23, D-37073 Göttingen
    Phone +49 (0) 551 / 39-5947
    E-Mail: peter.rehling@medizin.uni-goettingen.de

    Cluster of Excellence Multiscale Bioimaging (MBExC)
    Dr. Heike Conrad (Contact – Press Release)
    Phone 0551 39-61305
    E-Mail: heike.conrad@med.uni-goettingen.de


    Original publication:

    Original publication: An in vitro system to silence mitochondrial gene expression. Cruz-Zaragoza LD, Dennerlein S, Linden A,Yousefi R, Lavdovskaia E, Aich A Falk RR, Gomkale R, Schöndorf T, Bohnsack MT, Richter-Dennerlein R, Urlaub H, Rehling P (2021) Cell, 184, 1-14. doi: 10.16/j.cell.2021.09.033.


    Images

    f.l.: First author, Dr. Luis Daniel Cruz-Zaragoza, scientist at the Department of Cellular Biochemistry, UMG, and senior author, Prof. Dr. Peter Rehling, Director of the Department of Cellular Biochemistry, UMG.
    f.l.: First author, Dr. Luis Daniel Cruz-Zaragoza, scientist at the Department of Cellular Biochemis ...
    Photo: R. Yousefi, UMG.

    The image shows mouse hepatocytes where the process of mitochondrial translation is visualized (magenta) within the mitochondrial matrix enclosed by the mitochondrial membrane (green).
    The image shows mouse hepatocytes where the process of mitochondrial translation is visualized (mage ...

    Source: R. Yousefi, Department of Cellular Biochemistry, UMG.


    Criteria of this press release:
    Journalists
    Biology, Medicine
    transregional, national
    Research results, Scientific Publications
    English


     

    Help

    Search / advanced search of the idw archives
    Combination of search terms

    You can combine search terms with and, or and/or not, e.g. Philo not logy.

    Brackets

    You can use brackets to separate combinations from each other, e.g. (Philo not logy) or (Psycho and logy).

    Phrases

    Coherent groups of words will be located as complete phrases if you put them into quotation marks, e.g. “Federal Republic of Germany”.

    Selection criteria

    You can also use the advanced search without entering search terms. It will then follow the criteria you have selected (e.g. country or subject area).

    If you have not selected any criteria in a given category, the entire category will be searched (e.g. all subject areas or all countries).